Treatments · Entity Annotation Prototype (beta)

3articles mentioning treatments

3treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: anti-VEGF therapy ×

anti-VEGF therapy

This treatment is selected. Its supporting articles are shown below.

anti-VEGF therapy3

Articles mentioning anti-VEGF therapy

3 articles · page 1 of 1

Treatment of spontaneous hyphema in Fuch’s heterochromic iridocyclitis with intravitreal anti-VEGF ranibizumab

bmjcr · abstract · 2026-07-17 · 1 matching annotations

77.5%

anti-VEGF therapy ranibizumab Amsler’s sign

…of persistent chronic ocular hypertension. This case highlights anti-VEGF therapy as a potential adjunctive strategy in selected patients present…

Paradoxical resolution of refractory subretinal fluid in dome-shaped macula after discontinuation of anti-VEGF therapy

bmjcr · abstract · 2026-07-09 · 1 matching annotations

77.0%

anti-VEGF therapy faricimab ranibizumab aflibercept DSM Chronic subretinal fluid chronic SRF SRF

…ed stable. This suggests that in DSM, chronic SRF refractory to anti-VEGF therapy may spontaneously resolve after discontinuing treatment. Observ…

Tracking real-world persistence and adherence to anti-VEGF intravitreal therapy with prefilled syringes: a German prescription sales analysis

bmjophth · abstract · 2025-11-02 · 1 matching annotations

75.9%

Intravitreal antivascular endothelial growth factor (anti-VEGF) therapy anti-VEGF therapy neovascular age-related macular degeneration retinal vascular diseases

…Objective Intravitreal antivascular endothelial growth factor (anti-VEGF) therapy is the standard treatment for neovascular age-related macular d…